SIA "CHEMI PHARM LATVIA"Active

40003635989Limited liability companyFounded 2003

Key figures

2 243 555 €+12,1%
Revenue 2025
+9,1%
Average annual growth 2008–2025
01 m2 m3 m’08’09’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
0200 k400 k600 k’08’09’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

No dividends were paid.

History
20250 €
2024 ~150 000 €
2023 ~250 000 €
20220 €
2021 ~518 624 €
20200 €
20190 €
2018 ~190 338 €
2017 ~31 056 €
2016 ~34 256 €
2015 ~12 537 €
20140 €
2013 ~5355 €
20120 €
20110 €
20100 €
20090 €
20080 €
Summary of financial statements2008–2025
200820092010201120122013201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets127 247139 492155 536156 550151 685183 067227 733274 665303 595285 794346 014204 344554 649323 388410 256275 702295 900276 083
Total non-current assets2270955476237592702606223 87422 80918 38516 40112 94824 21434 78020 78714 845960364225158
Total assets129 517140 447160 298160 309154 387189 129251 607297 474321 980302 195358 962228 558589 429344 175425 101285 305302 322281 241
Balance sheet — liabilities and equity
Current liabilities24 84930 43732 33028 878928831 17826 40271 80380 305102 466100 593168 07961 41450 86127 82565 423186 363104 212
Non-current liabilities0000000029 2890215 9020000000
Total liabilities24 84930 43732 33028 878928831 17826 40271 803109 594102 466316 495168 07961 41450 86127 82565 423186 363104 212
Share capital——————————————————
Retained earnings of previous periods——————————————————
Profit for the year23 954644318 007391913 43417 47616 84714 25921 74518 39933 07618 012467 536283 923103 96272 60646 07761 070
Total equity103 051109 494127 501131 420144 854156 975223 175224 897212 386199 72942 46760 479528 015293 314397 276219 882115 959177 029
Income statement
Sales revenue512 061404 872515 434540 559681 277676 5181 008 5571 114 6691 343 1971 440 8291 489 7031 259 6332 345 6362 280 9331 808 5401 910 5652 001 8002 243 555
Operating profit30 727941724 618651916 75321 97519 10216 89225 88322 23734 60519 597468 588284 354105 07272 60683 57761 070
Profit before income tax30 133837923 216504916 14221 57018 73616 32825 10521 59133 25318 393467 585283 923103 96272 60683 57761 070
Profit for the reporting year23 954644318 007391913 43417 47616 84714 25921 74518 39933 07618 012467 536283 923103 96272 60646 07761 070
Labour costs——————————————————
Depreciation of non-current assets——————————————————
Other indicators
Employees763333334444457777
Calculated dividend000005355012 53734 25631 056190 33800518 6240250 000150 0000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a node to see its other connections.

100%SIA "CHEMI PHARM LATV…3Čižo Edmunds
CompanyPersonShareholderOther roleAdditional link

Related companies

Summary: SIA "CHEMI PHARM LATVIA"

Overview

SIA "CHEMI PHARM LATVIA" (reg. no. 40003635989) is a limited liability company. The company was registered in 2003 and has been in the register for 23 years. Registered address: Rīga, Īslīces iela 5 - 29.

Financial results

Revenue in 2025 was 2 243 555 €, up 12,1% on the previous year (2 001 800 €). From 2008 to 2025, revenue grew by an average of 9,1% per year. Net profit for 2025 was 61 070 € (2,7% of revenue). The company was profitable in all 18 published years. In 2025 the company had 7 employees. Revenue per employee was 320 508 €. At the end of 2025, total assets were 281 241 € and equity 177 029 € (62,9% of assets).

Management and owners

The company has one board member. The sole owner of the company is a private individual.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.